Insilico Medicine's Partnership

Insilico Medicine raised a round of funding on August 16, 2017. Investors include GlaxoSmithKline.

Insilico Medicine aims to extend healthy longevity through innovative AI solutions for drug discovery and aging research. The company has developed a drug discovery engine, which utilizes millions of …

Articles about Insilico Medicine's Partnership: